Physician profile
Christopher Arant
NPI 1083787089
$10,714.80
in general payments reported to CMS, 2019-2025
12 companies · $4,773 in 2025
The $4,773 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.54 · 2020: $537 · 2022: $107 · 2023: $2,342 · 2024: $2,920 · 2025: $4,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,943 · Food and Beverage: $3,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,943.00 |
| Food and Beverage | $3,092.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,465.94 | 2024-2025 | Versacross Access Solution, Avvigo Guidance System, Rotapro |
| Penumbra, INC. | $2,482.28 | 2025 | Indigo System |
| Abbott Laboratories | $2,147.94 | 2023 | Amplatzer Amulet |
| Medtronic Vascular, INC. | $472.36 | 2020 | |
| Shockwave Medical, INC | $369.98 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $176.23 | 2020-2024 | Onyx Frontier |
| Edwards Lifesciences Corporation | $143.91 | 2023-2025 | Swan-Ganz |
| Angiodynamics, INC. | $143.88 | 2024 | Angiovac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.42 | 2019-2024 | Lifevest |
| Acist Medical Systems, INC. | $82.97 | 2024-2025 | |
| Inari Medical, INC. | $66.95 | 2022 | |
| Abiomed | $50.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Arant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.